Resonant Asset Management - Director, Nick Morton
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

1. COVID – impact of second wave

Clearly Australia has faired better than most in terms of COVID-19 outcomes, driven partly by the skill of policy makers and politicians, but also by geography, and our relative ease in social distancing when compared to more urban and vertical living conditions, of say, New York or London.

The key discussion now has moved from flattening the curve to prospects of a second wave. Historically significant epidemiological events have been characterized by multiple phases, for instance the “Spanish” Influenza of 1918-1919. This looks unlikely to be an exception in that regard (

The government response function is evolving however, from lockdowns, which cause such grave mental health and economic outcomes, to controlled shutdowns of local areas where clusters have occurred.

This is primarily driven by an incrementally better understanding of the illness, and its associated death rate, which is lower than was initially feared. In addition, we are slowly refining treatments for the more severe cases of COVID-19 – reviewing the effectiveness of ventilators and intubation.

We still have much to learn about the virus, how it spreads, and who it impacts, and how to treat, but vast progress is and will be made over the next year or two.

For now, we can expect however that virus case numbers will not be driving markets as much as was the case in March/April, even if a second wave were to materialize. This is probably best surmised by US treasury secretary Steve Mnuchin on the 12th of June 2020, when he said that, We can’t shut down the economy again. I think we’ve learned that if you shut down the economy, you’re going to create more damage.” (

2. Earnings and Valuations

A great deal of uncertainty still lingers on corporate earnings.

The key barometer for us to gauge how far through the downgrades we sit lies in profit margins.

We previously published this ready reckoner on profit margins and revenues, to estimate earnings impact. On this basis, back in March we thought we might be looking at approximately 30% downgrades to earnings, with a target of net profit margins of 10% at the trough, and a 5% hit to revenues.

As at the end of May, Net Margin forecasts for 12 months ahead for the S&P/ASX 100 ex Financials were sitting at 11.7%, having fallen from 12.9% as at the end of February.

We still see 10% as a realistic target for trough level margins, but this will unlikely be reached until July & August or so, as we move into reporting season. We currently sit at downgrades of 15% since the end of February, so we are approximately half way through the earnings recession.

We do note however that the size of the stimulus, and the handling of the economic fall out, has so far been above expectations, so we might be approximately two thirds of the way through.

That projection of 25% peak to trough earnings recession, which is milder than our initial projection 30% drop, would leave us on a 12 month forward P/E of 19.6x as at the end of May. While superficially this seems expensive, we would re-iterate that in the context of a cash rate of 0.16%, it is nothing worse than mid-cycle.

3. Stimulus

The local fiscal stimulus programs look to be unwound in September this year, as the economy re-opens. Fiscal stimulus has successfully in many cases allowed businesses to hibernate successfully through this period.

Globally the Fed has drowned out any other global action in terms of the sheer scale and breadth of its support – it has become the only game in town, distorting the US Equity Market, and driving down the US Dollar.

On our analysis of the US Equity Market, we do see definite signs that the rally is getting frothy, and uniquely and entirely it seems driven by stimulus (incidentally the domestic market has not run as hard, multiples look more sober, and ultimate earnings impact, given the short length of the output gap, should be less pronounced).

For the US Equity market at least; the sugar hit of the April Fed stimulus looks to be running out of incremental puff – the clear message now is we need earnings and the real economy to drive the market higher. That is regardless of how many Fed liquidity interventions occur in between; without a complete lockdown, it will be hard for the Fed to justify much more drastic action to support markets.

This is somewhat of a heightened risk for much else of the global equities landscape, though we feel a bout of US Dollar strength should some of the hot air come out of the US Equity market is inevitable.

4. Consumer Demand

One major topic we are wrestling with is how is the average Australian household going to respond to the crisis on a medium term basis?

Since the end of March, the Government has responded extremely quickly and effectively to stave off the pronounced dip in Consumer spending – with in our view spectacular results.

In amongst the JobKeeper and other fiscal programs is the early release super scheme, which has dramatically increased the spending power of those of working age. The early release super scheme in our view was a well conceived and highly effective stimulus program.

How persistent are these programs and what are the prospects for this to continue?

The early super release scheme has already enabled nearly 2 million Australians to monetise $14.8Bn of long term super savings (, at an average $7500, over a 6 week period since end April.

That represents a huge cash injection to individuals at a time when they needed it the most.

As a result, we have already seen some extraordinary sales upgrades for FY20 from selected retailers, including JB Hi-Fi ($500m extraordinary sales since end April), Harvey Norman ($150mm), Wesfarmers ($800mm), which would only represent about 10% of the cash redeemed from superannuation.

At some point this stimulus will peter out and that might impact these retailers hard – but in the short term this has been a very effective means of getting some consumer spending in the economy and bridging the output gap introduced by lockdowns.

And this stimulus looks set to last until September or so and promises to continue to deliver a boost to consumption over that period.

In the longer term the economy will face challenges rekindling animal spirits amongst an over-indebted household sector, potentially struggling for employment, and without the incremental activity brought about by persist immigration programs, and international education, which have such a profound and consistent impact on demand.

5. Commodities

Iron Ore has now breached $100 US as Brazilian mine closures dampen supply, and investors anticipate a raft of stimulatory infrastructure spending as occurred in 2009. Mining is one industry where Australia’s handling of the crisis is likely to reap rewards relative to countries less fortunate.

$100 is typically a peak cycle iron ore price since the mining boom ended in 2011, so we do see some risks of mean reversion of coming months. And mean reversion is what the futures market is anticipating, with a futures price around $90 USD at year end.

This is already well anticipated by the market

This would explain why valuations for the iron ore miners remain subdued (12.9x 12m forward RIO, 15.2x BHP), despite iron ore fetching such a hefty premium.

However, margins for producers such as RIO Tinto, BHP and Fortescue have never been stronger, particularly when you consider the comparatively lower cost of wages on the back of an increase supply of available labour.

There are numerous risks around iron ore, however; that China’s investment in hard assets comes in below expectations; that it seeks to pro-actively diversify its source of the raw material away from Australia amongst simmering trade tensions; or that it increases the proportion of scrap in its steel making.

IMPORTANT NOTICE: This email is published by Resonant Asset Management Pty Ltd ABN 41 619 513 076, AFSL No 511759 (Resonant). It is intended for the exclusive use of the recipient client firm (Client) and its authorised representatives only. Please read the following before making any investment decision regarding any financial product mentioned within this email:

Disclosure: Resonant may receive a fee to provide consulting advice and recommendations to the Client, including the contents of this email. Resonant’s fees are not linked to the financial product rating(s) outcome or the inclusion of financial products in model portfolios, or in approved product lists. Resonant may hold the financial product(s) referred to in this email. Resonant’s representatives and/or their associates may hold any financial product referred to in this email.

Warnings: The Information within this document does not constitute personal financial advice. In preparing this document, Resonant has not taken into account your particular goals and objectives, anticipated resources, current situation or attitudes. You should therefore consider the appropriateness of the material in light of your own objectives, financial situation or needs, before taking any action. You should also obtain a copy of the PDS of all products referenced before making any decisions. The data, information and research commentary within this document may be derived from information obtained from other parties which cannot be verified by Resonant and therefore is not guaranteed to be complete or accurate, and Resonant accepts no liability for errors or omissions. Resonant does not guarantee the performance of any fund, stock or the return of an investor’s capital. Past performance is not a reliable indicator of future performance.

Disclaimer: All information within this document is intended for the Client and its authorised representatives only. The contents of this document is not intended for use by retail clients or members of the public and should not be relied upon by any other person. Resonant provides consulting advice in the construction of model portfolios and investment advice, which may be tailored to the Client’s requirements. However, these model portfolios and the investment advice remain the responsibility of the Client and may include financial product(s) that have been added at the Client’s request. In addition, depending upon the frequency with which changes are updated, they may not always reflect Resonant’s current recommendations. No representation, warranty or undertaking is given or made in relation to the accuracy or completeness of the information presented within this email, which may include public information not verified by Resonant. Recommendations are reasonably held at the time of completion (refer to the date of this email) but subject to change without notice. Except for any liability which cannot be excluded, Resonant, its directors, officers, employees and agents disclaim all liability for any error or inaccuracy in, misstatement or omission from, this email or any loss or damage suffered by the reader or any other person as a consequence of relying upon it.

More From The Market Online
The Market Online Video

Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market

Pharmaceutical companies can bring new hope to patients by delivering solutions to unmet medical needs. They…